73 results on '"Åsberg, Anders"'
Search Results
2. Very Low Frequency of Pathological Findings in One-year Protocol Biopsies of Uneventful Standard Risk Kidney Transplant Recipients: Results From the Nordic Protocol Biopsy Study.
3. Tacrolimus Measured in Capillary Volumetric Microsamples in Pediatric Patients--A Cross-Validation Study.
4. Prednisolone and Prednisone Pharmacokinetics in Adult Renal Transplant Recipients.
5. Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling.
6. Tacrolimus Can Be Reliably Measured With Volumetric Absorptive Capillary Microsampling Throughout the Dose Interval in Renal Transplant Recipients.
7. Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
8. A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients.
9. Determination of Tacrolimus Concentration and Protein Expression of P-Glycoprotein in Single Human Renal Core Biopsies.
10. High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation.
11. Exposure to Mycophenolate and Fatherhood.
12. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
13. Associations Between Posttransplantation Diabetes Mellitus and Renal Graft Survival.
14. Impact of Fasting Status and Circadian Variation on the Pharmacokinetics of Mycophenolate Mofetil and the Glucuronide Metabolite in Renal Transplant Recipients.
15. Poor Physical Function Trajectory Predicts Impaired Patient Survival in Older Recipients of Deceased Donor Kidneys: A Prospective Cohort Study.
16. Prediction of Fat-Free Mass in Kidney Transplant Recipients.
17. Chronic musculoskeletal complaints as a predictor of mortality-The HUNT study.
18. Closer to the Site of Action: Everolimus Concentrations in Peripheral Blood Mononuclear Cells Correlate Well With Whole Blood Concentrations.
19. Improved Tacrolimus Target Concentration Achievement Using Computerized Dosing in Renal Transplant Recipients--A Prospective, Randomized Study.
20. How to Report and Interpret Bioequivalence Data in Solid Organ Transplant Recipients.
21. Aortic Stiffness in a Mortality Risk Calculator for Kidney Transplant Recipients.
22. Limitations of Hemoglobin A1c for the Diagnosis of Posttransplant Diabetes Mellitus.
23. Use of Generic Tacrolimus in Elderly Renal Transplant Recipients.
24. Increased Osteoprotegerin Predicts Poor Virological Outcome During Anticytomegalovirus Therapy in Solid Organ Transplant Recipients.
25. More Potent Lipid-Lowering Effect by Rosuvastatin Compared With Fluvastatin in Everolimus-Treated Renal Transplant Recipients.
26. Endothelial Dysfunction and 6-Year Risk of Mortality in Kidney Transplant Recipients.
27. Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation.
28. Endothelial Dysfunction Is Associated With Graft Loss in Renal Transplant Recipients.
29. Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients.
30. The Concentration of Cyclosporine Metabolites Is Significantly Lower in Kidney Transplant Recipients With Diabetes Mellitus.
31. Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients.
32. The Clinical Utility of Whole Blood Versus Plasma Cytomegalovirus Viral Load Assays for Monitoring Therapeutic Response.
33. International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation.
34. Computer-Assisted Cyclosporine Dosing Performs Better Than Traditional Dosing in Renal Transplant Recipients: Results of a Pilot Study.
35. Rimonabant Affects Cyclosporine A, but Not Tacrolimus Pharmacokinetics in Renal Transplant Recipients.
36. Reduced Elimination of Cyclosporine A in Elderly (>65 Years) Kidney Transplant Recipients.
37. Declining Intracellular T-Lymphocyte Concentration of Cyclosporine A Precedes Acute Rejection in Kidney Transplant Recipients.
38. Calcineurin Inhibitor Avoidance with Daclizumab, Mycophenolate Mofetil, and Prednisolone in DR-Matched de Novo Kidney Transplant Recipients.
39. GENE EXPRESSION OF THE RENAL ENDOTHELIN SYSTEM IN RENAL TRANSPLANT RECIPIENTS ON CYCLOSPORINE A BASED IMMUNOSUPPRESSION.
40. The Importance of Using Serially Measured Tacrolimus Clearance Values, Especially During the Early Posttransplantation Period.
41. Mycophenolate Acid and Balancing the Risk for Male Allograft Recipients.
42. Long-term Kidney Transplant Survival Across the Globe.
43. Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating?
44. Cytomegalovirus High-risk Kidney Transplant Recipients Show No Difference in Long-term Outcomes Following Preemptive Versus Prophylactic Management.
45. Kidney-transplanted Adolescents-Nonadherence and Graft Outcomes During the Transition Phase: A Nationwide Analysis, 2000-2020.
46. Posttransplant Hypertension Matters!
47. Low Immunization Rate in Kidney Transplant Recipients Also After Dose 2 of the BNT162b2 Vaccine: Continue to Keep Your Guard up!
48. Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
49. The Authors' Reply: Placental Pathology in Pregnancies After Kidney Transplantation.
50. Immunosuppression and Reproductive Health After Kidney Transplantation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.